MEDNAX (MD) Misses Q3 EPS by 2c, Guides Q4 EPS Below the Street
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Raymond James Downgrades Mednax (MD) to Market Perform
October 27, 2016 10:05 AM EDTRaymond James downgraded Mednax (NYSE: MD) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Mednax click here. For more ratings news on Mednax click here.
Shares of Mednax closed at $65.00 yesterday.
... More